Skip to main content

Table 1 Baseline demographic characteristics of participants

From: Palliation of chronic breathlessness with morphine in patients with fibrotic interstitial lung disease – a randomised placebo-controlled trial

 

Morphine group

Placebo group

Age (years)

72.5 [69.8–79.8]

75.2 [72.7–77.8]

Female (%)

16.6

16.6

BMI

28.8 ± 4.9

27.8 ± 3.7

FVC baseline (%)

73.5 ± 4.8

77 ± 6.2

DLCO baseline %

38.5 [28–50]

29.5 [26–39]

LTOT, No (%)

7 (39)

3 (6)

Diagnosis

 Idiopathic Pulmonary Fibrosis

8

9

 Chronic Hypersensitivity Pneumonitis

1

3

 Connective tissue disease - ILD

4

4

 Unclassifiable ILD

2

1

 Idiopathic non-specific interstitial pneumonia

2

1

 Sarcoidosis

1

0

  1. BMI body mass index, FVC forced vital capacity, DLCO diffusing capacity for carbon monoxide, LTOT long term oxygen therapy, ILD interstitial lung disease